Some studies have reinforced the concept that small intestinal bacterial overgrowth (SIBO) plays an important role in the pathogenesis of NAFLD through endotoxin of bacteria and a tumor necrosis factor (TNF) as effective mediators [7,8]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.